Articles tagged with Rheumatoid Arthritis
Researchers at Wayne State University have made a breakthrough discovery in the inflammatory stress mechanism driving rheumatoid arthritis. A specific IRE1a inhibitor was identified to prevent arthritis in animal models, offering new hope for treating this autoimmune disease.
Researchers found that Prevotella copri was more abundant in patients with newly diagnosed rheumatoid arthritis than healthy individuals or those with chronic, treated rheumatoid arthritis. The study suggests a possible link between the growth of this intestinal bacteria and the onset of autoimmune attacks on the joints.
Researchers discovered that abnormal citrullination in rheumatoid joints is linked to pore-forming pathways in cell membranes. These pathways, called perforin and complement, are normally used by the immune system to fight pathogens, but their disruption produces enzyme-activating imbalances of calcium ions.
Early, aggressive drug treatment shows promising results in patients with psoriatic arthritis, reducing joint damage and disability. A £550,000 clinical trial involving over 200 patients found significant improvements in joint and skin outcomes with tight control of disease activity.
A new study from Hospital for Special Surgery found that achieving low disease activity within six months significantly reduces disability at two years. Patients who reached this state had better functional ability and fewer joint damages compared to those who delayed treatment.
Mayo Clinic studies reveal that patients with rheumatoid arthritis are at increased risk of heart disease, with early menopause and a strong immune response to certain viruses being major contributors. The research also identifies specific biomarkers and blood test results that may indicate cardiovascular complications.
A recent study by the University of York found that copper bracelets and magnetic wrist straps offer no meaningful benefits for patients with active rheumatoid arthritis symptoms. Participants who wore these devices reported no significant improvements in pain, swelling, or disease progression compared to a placebo.
Researchers discovered that Porphyromonas gingivalis produces an enzyme that enhances collagen-induced arthritis, leading to earlier onset and greater severity of rheumatoid arthritis. The bacteria worsens joint destruction by changing proteins into citrulline, triggering an immune attack.
A new genomic characterization of remission in juvenile rheumatoid arthritis patients reveals that their immune systems remain perturbed even during symptom-free periods. The study highlights the importance of HNF4a as a master switch regulating therapeutic response, and its potential to inform personalized treatment strategies.
New research finds that a subpopulation of immune cells, known as T lymphocytes, have platelets bound to their surface, reducing activation and proliferation. This discovery opens the door to potential treatments targeting platelet binding to lymphocytes.
A major clinical trial has shown that specialist nurse-led clinics can manage people with rheumatoid arthritis just as effectively as traditional doctor-led services. The study found significant improvements in disease activity, pain control, and patient satisfaction, while also reducing healthcare costs.
Research published in Annals of Internal Medicine suggests that low diastolic blood pressure may be a significant risk factor for mortality in patients with CKD. A study of over 651,000 veterans found that those with diastolic blood pressures below 70mmHg had higher mortality rates compared to those within the recommended range.
A large nationwide study found that people with rheumatoid arthritis are at a higher risk of developing potentially fatal blood clots in the legs and lungs. The study revealed that patients with rheumatoid arthritis were more than twice as likely to develop these clots, with the risk being highest among younger adults.
A study found that biological tumor necrosis factor inhibitors did not significantly reduce work loss compared to conventional treatment in patients with early rheumatoid arthritis. Early and aggressive treatment can help reverse increasing work loss days, but the cost of infliximab outweighs its benefits.
Researchers at Turku Centre for Biotechnology and Aalto University have discovered a new epigenetic mechanism that regulates lymphocyte function. This breakthrough provides insight into the emergence of immune-mediated diseases such as type 1 diabetes, rheumatoid arthritis, and inflammatory bowel disease.
A new study found that patients with early arthritis consume significantly less alcohol than healthy controls, with an inverse association between drinking and the presence of all forms of arthritis. The study also suggests that men may be more susceptible to the influence of alcohol on RA pathophysiology.
New antibody biomarkers could significantly improve diagnosis in rheumatoid arthritis by detecting the disease in patients who test negative for existing diagnostic antibodies. The study found that these biomarkers were present in both early and seronegative disease, indicating their potential to close the diagnostic gap in RA.
A nurse-led program improved patient self-assessment and led to changes in drug therapy among 89% of participants. The program also showed significant actions taken to reduce comorbidities, particularly cardiovascular disease, at a rate of 17.2%.
A new study reveals overweight and obese patients are less likely to achieve successful remission in early rheumatoid arthritis. These patients require 2.4 times more anti-TNF therapy to achieve similar outcomes.
Women who have given birth are at a higher risk of developing ACPA-negative rheumatoid arthritis, according to a new study. The increased risk is more pronounced among those who deliver within the first year of symptoms.
A study analyzing US data reveals that up to one-third of rheumatoid arthritis patients discontinue therapy within the first year, with loss of efficacy being the leading reason. The findings highlight the need for early intervention and improved adherence to treatment to enable patients to lead active lives.
A new study demonstrates the efficacy of a radiographic scoring method to evaluate joint damage in rheumatoid arthritis, revealing progressive destruction even under TNF-blocking therapies. Patients with pre-existing damage showed significant increases in joint damage, highlighting the importance of early and accurate evaluation.
A head-to-head trial shows that subcutaneous abatacept is as effective as adalimumab in clinical and functional outcomes for patients with active rheumatoid arthritis. The study found comparable efficacy and safety profiles between the two treatments, with fewer injection site reactions in the abatacept group.
RA patients identified seven key categories essential for adopting and maintaining physical activity, including personal incentives, peer support, and professional coaching. The study aimed to develop an internet-based physical activity intervention that caters to these needs, promoting exercise habits among RA patients.
Two studies assess joint replacement outcomes in patients with RA, overturning the common belief that RA patients have worse outcomes after a total knee replacement. RA patients who undergo hip replacement show similar improvements in function and pain as osteoarthritis patients.
Researchers at Mayo Clinic found that patients with gout who initially experience pain in other joints, such as the knee or elbow, are at higher risk of future flare-ups. Additionally, chronic blood pressure variability and smoking are linked to increased cardiovascular risk in rheumatoid arthritis patients.
A new study found that only one-fifth of rheumatoid arthritis patients took their oral medications at 80% or greater. Researchers emphasize the importance of following the prescribed regimen to manage disease symptoms and prevent progression. Patients with better mental health status were more likely to adhere to their medication regimen.
A study by Johns Hopkins Medicine reveals that a subset of antibodies, PAD3/PAD4 cross-reactive autoantibodies, may serve as a diagnostic marker for the most severe form of rheumatoid arthritis. The presence of these antibodies is associated with aggressive inflammation and connective tissue damage.
The BMJ argues that clinicians and patients must work together to challenge entrenched practices and behaviours in healthcare. The journal emphasizes the importance of patient partnership in improving health systems and encourages a fundamental shift in power structures.
Researchers found that pro-factor D, a protein secreted by fat cells in the knee joint, is linked to rheumatoid arthritis. The discovery could lead to new gene therapies to eliminate the protein and prevent disease progression.
Researchers found that even light smoking increases the risk of rheumatoid arthritis, with a doubling of risk for those who smoke 1-7 cigarettes per day. Stopping smoking after 15 years reduces the risk, but it remains higher than non-smokers.
A new study finds that women with RA exposed to methotrexate have lower induced abortion rates compared to unexposed women. However, those exposed to anti-TNF medications, such as Enbrel and Humira, may have higher abortion rates.
Research suggests hormonal changes may precede development of rheumatoid arthritis in men. Men with low testosterone levels were found to be more likely to develop the disease, even after adjusting for other risk factors.
Researchers found a link between lifestyle factors and an increased risk of developing rheumatoid arthritis, with smoking, obesity, and diabetes being key contributors. The study also identified reduced risks associated with moderate alcohol consumption and higher social class.
A large study of nearly 60,000 patients with rheumatoid arthritis and other inflammatory diseases found that initiating anti-tumor necrosis factor therapies did not significantly increase the risk of herpes zoster. Corticosteroid use was associated with a higher risk of herpes zoster in this population.
Researchers at UT Arlington are developing individualized rehabilitation software systems that use remote monitoring of people with rheumatoid arthritis to increase compliance and proper physical therapy. The system collects physiological and cognitive data while engaging patients in interactive game-like structured activities.
Studies reveal that blocking TGF-β can prevent tumor recurrence in mice with triple negative breast cancer. Additionally, targeting specific subsets of immune cells, such as CD8+ regulatory T-cells, may provide a new approach to treating rheumatoid arthritis.
A subset of regulatory T cells has been identified that can remove pathogenic T cells, inhibiting disease progression in RA-like conditions. Small proteins have also been found to induce more of these beneficial T cells.
Researchers at Dana-Farber Cancer Institute have developed a new approach to treating autoimmune diseases like rheumatoid arthritis. Infusing CD8+ Treg cells into arthritis-prone mice shut down the inflammatory cascade that damages tissues and joints, significantly slowing disease progression.
Regular sunlight exposure is linked to lower risk of developing rheumatoid arthritis in older women due to increased production of vitamin D. However, younger women who cover up with sunscreen may not experience the same protective benefits, according to a large-scale study.
IRHOM2 is a protein that regulates TACE on immune cells, and blocking it could provide an effective treatment for rheumatoid arthritis. Researchers found that mice deficient in IRHOM2 were protected from inflammatory arthritis.
A University of Michigan study reveals how certain genes activate cells that cause rheumatoid arthritis in mice, potentially leading to new treatments for both arthritis and other autoimmune diseases. The discovery challenges long-held theories on the association between HLA genes and autoimmune disorders.
A Phase 3 clinical trial shows that tofacitinib preserves joint structure in RA patients with moderate to severe disease, reducing progression of joint erosion and narrowing. The medication is effective in treating RA symptoms and reducing the rate of joint damage, providing new evidence for its treatment.
Researchers found a clear role for regulatory 'tags' in mediating genetic risk for rheumatoid arthritis, an immune disorder affecting 1.5 million American adults. The study identified 10 DNA sites tagged differently in RA patients and associated with disease risk.
A systemic review of evidence found that rheumatoid arthritis (RA) patients have a higher risk of hip dislocation and infection following total joint arthroplasty, particularly hip replacement surgery. This study suggests that RA patients face increased complications compared to osteoarthritis (OA) patients.
Researchers at the University of Manchester have identified 14 new genes linked to rheumatoid arthritis, shedding light on why the condition disproportionately affects women. The study's findings could lead to personalized treatment approaches and improved disease management.
Studies found that lupus patients who underwent knee replacement surgery experienced few adverse events, with outcomes similar to those of osteoarthritis patients. Rheumatoid arthritis (RA) patients also performed similarly after joint replacement surgery, with no significant differences in operation time or post-surgical complications.
Researchers found that rheumatoid arthritis patients are at higher risk for cancer, broken bones increase cardiovascular disease and death, and corticosteroids remain a common treatment despite newer options. Gut bacteria also holds promise as an anti-inflammatory treatment for autoimmune disorders.
A recent study published in the Journal of Clinical Nursing found that nearly a quarter of patients with rheumatoid arthritis and osteoarthritis used complementary and alternative therapy (CAT) to manage their condition. The majority reported improvements in pain intensity, sleeping patterns, and activity levels after using CAT.
A research team at VIB has identified a new anti-inflammatory mechanism of the protein A20, which can help treat autoimmune diseases like Rheumatoid Arthritis. By understanding how A20 interacts with signaling pathways, scientists can develop new therapies to combat inflammation and disrupt the immune system's attack on its own tissues.
Scientists at Northwestern University have created a mouse model that replicates the human response in rheumatoid arthritis. The new prototype uses human stem cells implanted in mice, which showed authentic human reactions, paving the way for more accurate drug discovery and treatment options.
A Swedish study of over 45,000 patients with rheumatoid arthritis found an increased risk of venous thromboembolism, a blood clot that forms within a vein. The risk remained elevated for up to 10 years after diagnosis.
A Mayo Clinic study developed an infection risk score for rheumatoid arthritis patients, using factors like age, corticosteroid use and inflammation levels. The score helps physicians identify high-risk patients and take measures to prevent infections.
A meta-analysis of over 60 randomized controlled trials found no statistically significant increased risk of any type of cancer with biologic response modifiers in patients with rheumatoid arthritis. The study included 29,423 patients and followed them for at least 24 weeks.
Researchers have discovered that blocking GM-CSF action can suppress both pain and inflammation in experimental models of rheumatoid arthritis and osteoarthritis. This breakthrough could lead to a new therapy for patients suffering from debilitating conditions.
A study found that rheumatoid arthritis patients are four times more likely to develop gum disease, with severe cases associated with increased inflammatory markers and antibodies. Gum disease in these patients may contribute to the development and maintenance of systemic inflammation.
Researchers found no statistically significant difference in mortality rates among patients with rheumatoid arthritis (RA) who were exposed to adalimumab, etanercept, or infliximab. The study of RA patients in Sweden compared overall mortality rates among those treated with individual TNF inhibitors.
Researchers found that RA patients primarily cite joint pain as the reason for their perceived change in disease activity, while physicians emphasize swollen joints. The study's results suggest a discrepancy between patient and physician perceptions of disease activity, with potential implications for improved shared decision-making.
A new study finds that rheumatoid arthritis (RA) patients receive regular cancer screenings, including breast, cervical, and colon cancer tests, at similar rates to the general population. The study's results challenge previous research suggesting RA patients receive fewer cancer screenings.
Scientists have discovered a 'constant cloud' of potent inflammatory molecules surrounding the cells responsible for diseases like thickening of the arteries and rheumatoid arthritis. Monocytes, a type of white blood cell, were found to be surrounded by this constant cloud, which was propelled through the cell wall by lysosomes.